HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 15-JUL-21 7RGJ TITLE DFRA1 COMPLEXED WITH NADPH AND 5-(3-(7-(4-(AMINOMETHYL)PHENYL) TITLE 2 BENZO[D][1,3]DIOXOL-5-YL)BUT-1-YN-1-YL)-6-ETHYLPYRIMIDINE-2,4-DIAMINE TITLE 3 (UCP1223) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE TYPE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DIHYDROFOLATE REDUCTASE TYPE I,TRIMETHOPRIM RESISTANCE COMPND 5 PROTEIN; COMPND 6 EC: 1.5.1.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: DHFRI; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS INHIBITOR, COMPLEX, ANTIFOLATE, DHFR, OXIDOREDUCTASE, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.N.LOMBARDO,D.L.WRIGHT REVDAT 2 18-OCT-23 7RGJ 1 REMARK REVDAT 1 25-MAY-22 7RGJ 0 JRNL AUTH J.KRUCINSKA,M.N.LOMBARDO,H.ERLANDSEN,A.ESTRADA,D.SI, JRNL AUTH 2 K.VISWANATHAN,D.L.WRIGHT JRNL TITL STRUCTURE-GUIDED FUNCTIONAL STUDIES OF PLASMID-ENCODED JRNL TITL 2 DIHYDROFOLATE REDUCTASES REVEAL A COMMON MECHANISM OF JRNL TITL 3 TRIMETHOPRIM RESISTANCE IN GRAM-NEGATIVE PATHOGENS. JRNL REF COMMUN BIOL V. 5 459 2022 JRNL REFN ESSN 2399-3642 JRNL PMID 35562546 JRNL DOI 10.1038/S42003-022-03384-Y REMARK 2 REMARK 2 RESOLUTION. 1.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.920 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 65681 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3320 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.2900 - 4.1600 0.87 2444 140 0.1943 0.2290 REMARK 3 2 4.1500 - 3.3000 0.99 2643 140 0.1783 0.2143 REMARK 3 3 3.3000 - 2.8800 1.00 2715 106 0.1976 0.2134 REMARK 3 4 2.8800 - 2.6200 1.00 2653 140 0.2144 0.2417 REMARK 3 5 2.6200 - 2.4300 1.00 2618 148 0.2052 0.2192 REMARK 3 6 2.4300 - 2.2900 1.00 2590 182 0.2029 0.2180 REMARK 3 7 2.2900 - 2.1700 1.00 2628 122 0.1930 0.2199 REMARK 3 8 2.1700 - 2.0800 1.00 2638 134 0.2003 0.2284 REMARK 3 9 2.0800 - 2.0000 1.00 2596 133 0.1941 0.2442 REMARK 3 10 2.0000 - 1.9300 1.00 2611 151 0.2023 0.2460 REMARK 3 11 1.9300 - 1.8700 1.00 2593 141 0.1986 0.2211 REMARK 3 12 1.8700 - 1.8200 1.00 2609 129 0.2057 0.2249 REMARK 3 13 1.8200 - 1.7700 1.00 2579 153 0.1976 0.2068 REMARK 3 14 1.7700 - 1.7300 1.00 2576 166 0.2119 0.2601 REMARK 3 15 1.7300 - 1.6900 1.00 2581 120 0.2038 0.2491 REMARK 3 16 1.6900 - 1.6500 1.00 2595 135 0.2011 0.2423 REMARK 3 17 1.6500 - 1.6200 1.00 2626 140 0.2042 0.2228 REMARK 3 18 1.6200 - 1.5900 1.00 2616 128 0.2188 0.2677 REMARK 3 19 1.5900 - 1.5600 1.00 2554 146 0.2114 0.2108 REMARK 3 20 1.5600 - 1.5300 1.00 2596 145 0.2175 0.2591 REMARK 3 21 1.5300 - 1.5100 1.00 2531 143 0.2256 0.2362 REMARK 3 22 1.5100 - 1.4800 1.00 2606 144 0.2349 0.2599 REMARK 3 23 1.4800 - 1.4600 1.00 2580 134 0.2466 0.2986 REMARK 3 24 1.4600 - 1.4400 0.99 2583 100 0.2727 0.2945 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.154 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.634 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2849 REMARK 3 ANGLE : 1.098 3906 REMARK 3 CHIRALITY : 0.084 418 REMARK 3 PLANARITY : 0.006 479 REMARK 3 DIHEDRAL : 14.594 431 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7RGJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1000256690. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65686 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 62.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 1.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ECX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: IMIDAZOLE, CALCIUM CHLORIDE, PEG REMARK 280 6,000, PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.04933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 80.09867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 80.09867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 40.04933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CAM 8MU B 204 LIES ON A SPECIAL POSITION. REMARK 375 CAN 8MU B 204 LIES ON A SPECIAL POSITION. REMARK 375 CAQ 8MU B 204 LIES ON A SPECIAL POSITION. REMARK 375 CBA 8MU B 204 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 66 REMARK 465 ASP A 70 REMARK 465 GLY A 157 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 22 47.01 -84.26 REMARK 500 PRO B 22 48.52 -86.49 REMARK 500 ASP B 125 19.68 -147.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 397 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 398 DISTANCE = 6.97 ANGSTROMS DBREF 7RGJ A 1 157 UNP P00382 DYR1_ECOLX 1 157 DBREF 7RGJ B 1 157 UNP P00382 DYR1_ECOLX 1 157 SEQRES 1 A 157 MET LYS LEU SER LEU MET VAL ALA ILE SER LYS ASN GLY SEQRES 2 A 157 VAL ILE GLY ASN GLY PRO ASP ILE PRO TRP SER ALA LYS SEQRES 3 A 157 GLY GLU GLN LEU LEU PHE LYS ALA ILE THR TYR ASN GLN SEQRES 4 A 157 TRP LEU LEU VAL GLY ARG LYS THR PHE GLU SER MET GLY SEQRES 5 A 157 ALA LEU PRO ASN ARG LYS TYR ALA VAL VAL THR ARG SER SEQRES 6 A 157 SER PHE THR SER ASP ASN GLU ASN VAL LEU ILE PHE PRO SEQRES 7 A 157 SER ILE LYS ASP ALA LEU THR ASN LEU LYS LYS ILE THR SEQRES 8 A 157 ASP HIS VAL ILE VAL SER GLY GLY GLY GLU ILE TYR LYS SEQRES 9 A 157 SER LEU ILE ASP GLN VAL ASP THR LEU HIS ILE SER THR SEQRES 10 A 157 ILE ASP ILE GLU PRO GLU GLY ASP VAL TYR PHE PRO GLU SEQRES 11 A 157 ILE PRO SER ASN PHE ARG PRO VAL PHE THR GLN ASP PHE SEQRES 12 A 157 ALA SER ASN ILE ASN TYR SER TYR GLN ILE TRP GLN LYS SEQRES 13 A 157 GLY SEQRES 1 B 157 MET LYS LEU SER LEU MET VAL ALA ILE SER LYS ASN GLY SEQRES 2 B 157 VAL ILE GLY ASN GLY PRO ASP ILE PRO TRP SER ALA LYS SEQRES 3 B 157 GLY GLU GLN LEU LEU PHE LYS ALA ILE THR TYR ASN GLN SEQRES 4 B 157 TRP LEU LEU VAL GLY ARG LYS THR PHE GLU SER MET GLY SEQRES 5 B 157 ALA LEU PRO ASN ARG LYS TYR ALA VAL VAL THR ARG SER SEQRES 6 B 157 SER PHE THR SER ASP ASN GLU ASN VAL LEU ILE PHE PRO SEQRES 7 B 157 SER ILE LYS ASP ALA LEU THR ASN LEU LYS LYS ILE THR SEQRES 8 B 157 ASP HIS VAL ILE VAL SER GLY GLY GLY GLU ILE TYR LYS SEQRES 9 B 157 SER LEU ILE ASP GLN VAL ASP THR LEU HIS ILE SER THR SEQRES 10 B 157 ILE ASP ILE GLU PRO GLU GLY ASP VAL TYR PHE PRO GLU SEQRES 11 B 157 ILE PRO SER ASN PHE ARG PRO VAL PHE THR GLN ASP PHE SEQRES 12 B 157 ALA SER ASN ILE ASN TYR SER TYR GLN ILE TRP GLN LYS SEQRES 13 B 157 GLY HET NAP A 201 48 HET CA A 202 1 HET 8MU A 203 31 HET NAP B 201 48 HET CA B 202 1 HET 560 B 203 31 HET 8MU B 204 31 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM CA CALCIUM ION HETNAM 8MU 5-[(3S)-3-{7-[4-(AMINOMETHYL)PHENYL]-2H-1,3- HETNAM 2 8MU BENZODIOXOL-5-YL}BUT-1-YN-1-YL]-6-ETHYLPYRIMIDINE-2,4- HETNAM 3 8MU DIAMINE HETNAM 560 5-[(3R)-3-{7-[4-(AMINOMETHYL)PHENYL]-2H-1,3- HETNAM 2 560 BENZODIOXOL-5-YL}BUT-1-YN-1-YL]-6-ETHYLPYRIMIDINE-2,4- HETNAM 3 560 DIAMINE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 CA 2(CA 2+) FORMUL 5 8MU 2(C24 H25 N5 O2) FORMUL 8 560 C24 H25 N5 O2 FORMUL 10 HOH *208(H2 O) HELIX 1 AA1 GLY A 27 TYR A 37 1 11 HELIX 2 AA2 ARG A 45 GLY A 52 1 8 HELIX 3 AA3 SER A 79 THR A 91 1 13 HELIX 4 AA4 GLY A 99 ILE A 107 1 9 HELIX 5 AA5 GLY B 27 TYR B 37 1 11 HELIX 6 AA6 ARG B 45 GLY B 52 1 8 HELIX 7 AA7 SER B 79 THR B 91 1 13 HELIX 8 AA8 GLY B 99 ILE B 107 1 9 HELIX 9 AA9 ASP B 108 VAL B 110 5 3 SHEET 1 AA1 8 VAL A 74 PHE A 77 0 SHEET 2 AA1 8 LYS A 58 VAL A 62 1 N TYR A 59 O LEU A 75 SHEET 3 AA1 8 TRP A 40 GLY A 44 1 N LEU A 41 O ALA A 60 SHEET 4 AA1 8 HIS A 93 VAL A 96 1 O ILE A 95 N TRP A 40 SHEET 5 AA1 8 LYS A 2 SER A 10 1 N SER A 4 O VAL A 96 SHEET 6 AA1 8 THR A 112 ILE A 118 1 O HIS A 114 N LEU A 5 SHEET 7 AA1 8 TYR A 149 GLN A 155 -1 O SER A 150 N THR A 117 SHEET 8 AA1 8 ARG A 136 PHE A 143 -1 N VAL A 138 O ILE A 153 SHEET 1 AA2 2 VAL A 14 GLY A 16 0 SHEET 2 AA2 2 VAL A 126 TYR A 127 -1 O VAL A 126 N ILE A 15 SHEET 1 AA3 8 VAL B 74 PHE B 77 0 SHEET 2 AA3 8 LYS B 58 VAL B 62 1 N VAL B 61 O LEU B 75 SHEET 3 AA3 8 TRP B 40 GLY B 44 1 N LEU B 41 O ALA B 60 SHEET 4 AA3 8 HIS B 93 VAL B 96 1 O ILE B 95 N TRP B 40 SHEET 5 AA3 8 LYS B 2 SER B 10 1 N SER B 4 O VAL B 96 SHEET 6 AA3 8 THR B 112 ILE B 118 1 O SER B 116 N ILE B 9 SHEET 7 AA3 8 TYR B 149 LYS B 156 -1 O SER B 150 N THR B 117 SHEET 8 AA3 8 PHE B 135 PHE B 143 -1 N VAL B 138 O ILE B 153 LINK CA CA A 202 O HOH A 382 1555 4555 2.77 CISPEP 1 GLY A 98 GLY A 99 0 -1.67 CISPEP 2 GLY B 98 GLY B 99 0 1.20 CRYST1 72.279 72.279 120.148 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013835 0.007988 0.000000 0.00000 SCALE2 0.000000 0.015976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008323 0.00000